{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T20:02:21Z","timestamp":1773518541487,"version":"3.50.1"},"reference-count":148,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T00:00:00Z","timestamp":1594857600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T00:00:00Z","timestamp":1594857600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100006111","name":"Minist\u00e9rio da Ci\u00eancia, Tecnologia e Ensino Superior","doi-asserted-by":"publisher","award":["FCT\/MCTES; UID\/QUI\/50006\/2019"],"award-info":[{"award-number":["FCT\/MCTES; UID\/QUI\/50006\/2019"]}],"id":[{"id":"10.13039\/501100006111","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["204177\/2018-9, 308383\/2018-4, 403866\/2016-2, 30335"],"award-info":[{"award-number":["204177\/2018-9, 308383\/2018-4, 403866\/2016-2, 30335"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["23038.000936\/2018-46"],"award-info":[{"award-number":["23038.000936\/2018-46"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005283","name":"Funda\u00e7\u00e3o Cearense de Apoio ao Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["PR2 0101-00030.01.00\/15 SPU N\u00ba: 3265612\/2015"],"award-info":[{"award-number":["PR2 0101-00030.01.00\/15 SPU N\u00ba: 3265612\/2015"]}],"id":[{"id":"10.13039\/501100005283","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Biol Inorg Chem"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s00775-020-01803-1","type":"journal-article","created":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T12:02:47Z","timestamp":1594900967000},"page":"685-704","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Potential therapeutic approaches for a sleeping pathogen: tuberculosis a case for bioinorganic chemistry"],"prefix":"10.1007","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0007-8452","authenticated-orcid":false,"given":"Eduardo H. S.","family":"Sousa","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2765-4982","authenticated-orcid":false,"given":"Izaura C. N.","family":"Di\u00f3genes","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3641-1835","authenticated-orcid":false,"given":"Luiz G. F.","family":"Lopes","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4726-2388","authenticated-orcid":false,"given":"Jos\u00e9 J. G.","family":"Moura","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2020,7,16]]},"reference":[{"key":"1803_CR1","unstructured":"Global tuberculosis report 2019. Geneva: World Health Organization; 2019. License: CC BY-NC-SA 3.0 IGO. ISBN 978-92-4-156571-4"},{"issue":"2","key":"1803_CR2","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1080\/23744235.2017.1377346","volume":"50","author":"VK Gupta","year":"2018","unstructured":"Gupta VK, Kumar MM, Singh D, Bisht D, Sharma S (2018) Drug targets in dormant Mycobacterium tuberculosis: can the conquest against tuberculosis become a reality? Infect Dis-Nor 50(2):81\u201394. https:\/\/doi.org\/10.1080\/23744235.2017.1377346","journal-title":"Infect Dis-Nor"},{"issue":"4","key":"1803_CR3","first-page":"257","volume":"30","author":"WMC Dermott","year":"1958","unstructured":"Dermott WMC (1958) Microbial persistence. Yale J Biol Med 30(4):257\u2013291","journal-title":"Yale J Biol Med"},{"issue":"2","key":"1803_CR4","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s00281-015-0533-1","volume":"38","author":"CJ Martin","year":"2016","unstructured":"Martin CJ, Carey AF, Fortune SM (2016) A bug's life in the granuloma. Semin Immunopathol 38(2):213\u2013220. https:\/\/doi.org\/10.1007\/s00281-015-0533-1","journal-title":"Semin Immunopathol"},{"issue":"6","key":"1803_CR5","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.tim.2018.02.012","volume":"26","author":"A Koch","year":"2018","unstructured":"Koch A, Mizrahi V (2018) Mycobacterium tuberculosis. Trends Microbiol 26(6):555\u2013556. https:\/\/doi.org\/10.1016\/j.tim.2018.02.012","journal-title":"Trends Microbiol"},{"key":"1803_CR6","volume-title":"Review of medical microbiology and immunology","author":"W Levinson","year":"2016","unstructured":"Levinson W (2016) Review of medical microbiology and immunology, 14th edn. McGraw-Hill Education, San Francisco (ISBN 0071845755)","edition":"14"},{"issue":"8","key":"1803_CR7","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1128\/JB.183.8.2672-2676.2001","volume":"183","author":"C Boon","year":"2001","unstructured":"Boon C, Li R, Qi R, Dick T (2001) Proteins of Mycobacterium bovis BCG induced in the Wayne dormancy model. J Bacteriol 183(8):2672\u20132676. https:\/\/doi.org\/10.1128\/JB.183.8.2672-2676.2001","journal-title":"J Bacteriol"},{"issue":"5","key":"1803_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/femspd\/fty054","volume":"76","author":"J Prusa","year":"2018","unstructured":"Prusa J, Zhu DX, Stallings CL (2018) The stringent response and Mycobacterium tuberculosis pathogenesis. Pathog Dis 76(5):1\u201313. https:\/\/doi.org\/10.1093\/femspd\/fty054","journal-title":"Pathog Dis"},{"key":"1803_CR9","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.2147\/DDDT.S238148","volume":"14","author":"O Ekpenyong","year":"2020","unstructured":"Ekpenyong O, Gao X, Ma J, Cooper C, Nguyen L, Olaleye OA, Liang D, Xie H (2020) Pre-clinical pharmacokinetics, tissue distribution and physicochemical studies of CLBQ14, a novel methionine aminopeptidase inhibitor for the treatment of infectious diseases. Drug Des Devel Ther 14:1263\u20131277. https:\/\/doi.org\/10.2147\/DDDT.S238148","journal-title":"Drug Des Devel Ther"},{"issue":"19","key":"1803_CR10","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.2174\/1389557519666190625165512","volume":"19","author":"G Gutti","year":"2019","unstructured":"Gutti G, Arya K, Singh SK (2019) Latent tuberculosis infection (LTBI) and its potential targets: an investigation into dormant phase pathogens. Mini Rev Med Chem 19(19):1627\u20131642. https:\/\/doi.org\/10.2174\/1389557519666190625165512","journal-title":"Mini Rev Med Chem"},{"issue":"6","key":"1803_CR11","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.tube.2015.04.010","volume":"95","author":"PB Devi","year":"2015","unstructured":"Devi PB, Sridevi JP, Kakan SS, Saxena S, Jeankumar VU, Soni V, Anantaraju HS, Yogeeswari P, Sriram D (2015) Discovery of novel lysine varepsilon-aminotransferase inhibitors: an intriguing potential target for latent tuberculosis. Tuberculosis (Edinb) 95(6):786\u2013794. https:\/\/doi.org\/10.1016\/j.tube.2015.04.010","journal-title":"Tuberculosis (Edinb)"},{"issue":"3","key":"1803_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/microbiolspec.TBTB2-0014-2016","volume":"5","author":"GM Cook","year":"2017","unstructured":"Cook GM, Hards K, Dunn E, Heikal A, Nakatani Y, Greening C, Crick DC, Fontes FL, Pethe K, Hasenoehrl E, Berney M (2017) Oxidative phosphorylation as a target space for tuberculosis: success, caution, and future directions. Microbiol Spectr 5(3):1\u201322. https:\/\/doi.org\/10.1128\/microbiolspec.TBTB2-0014-2016","journal-title":"Microbiol Spectr"},{"issue":"2","key":"1803_CR13","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1080\/23744235.2017.1377346","volume":"50","author":"VK Gupta","year":"2018","unstructured":"Gupta VK, Kumar MM, Singh D, Bisht D, Sharma S (2018) Drug targets in dormant Mycobacterium tuberculosis: can the conquest against tuberculosis become a reality? Infect Dis (Lond) 50(2):81\u201394. https:\/\/doi.org\/10.1080\/23744235.2017.1377346","journal-title":"Infect Dis (Lond)"},{"issue":"2","key":"1803_CR14","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1054\/tuld.1998.0015","volume":"79","author":"LG Wayne","year":"1998","unstructured":"Wayne LG, Hayes LG (1998) Nitrate reduction as a marker for hypoxic shiftdown of Mycobacterium tuberculosis. Tuber Lung Dis 79(2):127\u2013132. https:\/\/doi.org\/10.1054\/tuld.1998.0015","journal-title":"Tuber Lung Dis"},{"issue":"13","key":"1803_CR15","doi-asserted-by":"publisher","first-page":"8294","DOI":"10.1074\/jbc.M114.591800","volume":"290","author":"V Malhotra","year":"2015","unstructured":"Malhotra V, Agrawal R, Duncan TR, Saini DK, Clark-Curtiss JE (2015) Mycobacterium tuberculosis response regulators, DevR and NarL, interact in vivo and co-regulate gene expression during aerobic nitrate metabolism. J Biol Chem 290(13):8294\u20138309. https:\/\/doi.org\/10.1074\/jbc.M114.591800","journal-title":"J Biol Chem"},{"issue":"2","key":"1803_CR16","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1021\/acs.chemrev.8b00209","volume":"119","author":"X Wang","year":"2019","unstructured":"Wang X, Wang X, Jin S, Muhammad N, Guo Z (2019) Stimuli-responsive therapeutic metallodrugs. Chem Rev 119(2):1138\u20131192. https:\/\/doi.org\/10.1021\/acs.chemrev.8b00209","journal-title":"Chem Rev"},{"issue":"2","key":"1803_CR17","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1021\/acs.chemrev.8b00338","volume":"119","author":"YC Ong","year":"2019","unstructured":"Ong YC, Roy S, Andrews PC, Gasser G (2019) Metal compounds against neglected tropical diseases. Chem Rev 119(2):730\u2013796. https:\/\/doi.org\/10.1021\/acs.chemrev.8b00338","journal-title":"Chem Rev"},{"issue":"8","key":"1803_CR18","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1021\/acs.accounts.7b00242","volume":"50","author":"SM Cohen","year":"2017","unstructured":"Cohen SM (2017) A bioinorganic approach to fragment-based drug discovery targeting metalloenzymes. Acc Chem Res 50(8):2007\u20132016. https:\/\/doi.org\/10.1021\/acs.accounts.7b00242","journal-title":"Acc Chem Res"},{"issue":"22","key":"1803_CR19","doi-asserted-by":"publisher","first-page":"10206","DOI":"10.1021\/acs.jmedchem.8b01363","volume":"61","author":"CV Credille","year":"2018","unstructured":"Credille CV, Dick BL, Morrison CN, Stokes RW, Adamek RN, Wu NC, Wilson IA, Cohen SM (2018) Structure-activity relationships in metal-binding pharmacophores for influenza endonuclease. J Med Chem 61(22):10206\u201310217. https:\/\/doi.org\/10.1021\/acs.jmedchem.8b01363","journal-title":"J Med Chem"},{"issue":"5","key":"1803_CR20","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1039\/C9SC05586J","volume":"11","author":"CN Morrison","year":"2020","unstructured":"Morrison CN, Prosser KE, Stokes RW, Cordes A, Metzler-Nolte N, Cohen SM (2020) Expanding medicinal chemistry into 3D space: metallofragments as 3D scaffolds for fragment-based drug discovery. Chem Sci 11(5):1216\u20131225. https:\/\/doi.org\/10.1039\/C9SC05586J","journal-title":"Chem Sci"},{"key":"1803_CR21","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.cbpa.2014.01.005","volume":"19","author":"M Dorr","year":"2014","unstructured":"Dorr M, Meggers E (2014) Metal complexes as structural templates for targeting proteins. Curr Opin Chem Biol 19:76\u201381. https:\/\/doi.org\/10.1016\/j.cbpa.2014.01.005","journal-title":"Curr Opin Chem Biol"},{"key":"1803_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/chem.201904699","author":"P Chellan","year":"2020","unstructured":"Chellan P, Sadler PJ (2020) Enhancing the activity of drugs by conjugation to organometallic fragments. Chem Eur J. https:\/\/doi.org\/10.1002\/chem.201904699","journal-title":"Chem Eur J"},{"key":"1803_CR23","doi-asserted-by":"publisher","DOI":"10.1039\/D0DT01365J","author":"LGF Lopes","year":"2020","unstructured":"Lopes LGF, Carvalho EM, Sousa EHS (2020) A bioinorganic chemistry perspective on the roles of metals as drug and targets against Mycobacterium tuberculosis\u2014a journey of opportunities. Dalton Trans. https:\/\/doi.org\/10.1039\/D0DT01365J","journal-title":"Dalton Trans"},{"issue":"18","key":"1803_CR24","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.2174\/0929867322666150408112357","volume":"22","author":"L Viganor","year":"2015","unstructured":"Viganor L, Skerry C, McCann M, Devereux M (2015) Tuberculosis: an inorganic medicinal chemistry perspective. Curr Med Chem 22(18):2199\u20132224. https:\/\/doi.org\/10.2174\/0929867322666150408112357","journal-title":"Curr Med Chem"},{"issue":"1","key":"1803_CR25","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ejmech.2010.10.004","volume":"46","author":"GM Maguene","year":"2011","unstructured":"Maguene GM, Jakhlal J, Ladyman M, Vallin A, Ralambomanana DA, Bousquet T, Maugein J, Lebibi J, Pelinski L (2011) Synthesis and antimycobacterial activity of a series of ferrocenyl derivatives. Eur J Med Chem 46(1):31\u201338. https:\/\/doi.org\/10.1016\/j.ejmech.2010.10.004","journal-title":"Eur J Med Chem"},{"key":"1803_CR26","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1039\/b313592f","volume":"3","author":"JS Oliveira","year":"2004","unstructured":"Oliveira JS, Sousa EHS, Basso LA, Palaci M, Dietze R, Santos DS, Moreira IS (2004) An inorganic iron complex that inhibits wild-type and an isoniazid-resistant mutant 2-trans-enoyl-ACP (CoA) reductase from Mycobacterium tuberculosis. Chem Commun (Camb) 3:312\u2013313. https:\/\/doi.org\/10.1039\/b313592f","journal-title":"Chem Commun (Camb)"},{"key":"1803_CR27","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.ica.2017.02.031","volume":"461","author":"RN Garner","year":"2017","unstructured":"Garner RN, Pierce CG, Reed CR, Brennessel WW (2017) Photoinitiated treatment of Mycobacterium using Ru(II) isoniazid complexes. Inorg Chim Acta 461:261\u2013266. https:\/\/doi.org\/10.1016\/j.ica.2017.02.031","journal-title":"Inorg Chim Acta"},{"issue":"1","key":"1803_CR28","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1039\/c6sc03028a","volume":"8","author":"NA Smith","year":"2017","unstructured":"Smith NA, Zhang P, Greenough SE, Horbury MD, Clarkson GJ, McFeely D, Habtemariam A, Salassa L, Stavros VG, Dowson CG, Sadler PJ (2017) Combatting AMR: photoactivatable ruthenium(ii)-isoniazid complex exhibits rapid selective antimycobacterial activity. Chem Sci 8(1):395\u2013404. https:\/\/doi.org\/10.1039\/c6sc03028a","journal-title":"Chem Sci"},{"issue":"4","key":"1803_CR29","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1039\/c9qi01172b","volume":"7","author":"ED Nunes","year":"2020","unstructured":"Nunes ED, Villela AD, Basso LA, Teixeira EH, Andrade AL, Vasconcelos MA, Neto LGD, Gondim ACS, Diogenes ICN, Romo AIB, Nascimento OR, Zampieri D, Paulo TF, de Carvalho IMM, Lopes LGD, Sousa EHS (2020) Light-induced disruption of an acyl hydrazone link as a novel strategy for drug release and activation: isoniazid as a proof-of-concept case. Inorg Chem Front 7(4):859\u2013870. https:\/\/doi.org\/10.1039\/c9qi01172b","journal-title":"Inorg Chem Front"},{"key":"1803_CR30","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.jinorgbio.2014.08.002","volume":"140","author":"EHS Sousa","year":"2014","unstructured":"Sousa EHS, de Mesquita Vieira FG, Butler JS, Basso LA, Santiago DS, Diogenes IC, Lopes LG, Sadler PJ (2014) [Fe(CN)5(isoniazid)]3-: an iron isoniazid complex with redox behavior implicated in tuberculosis therapy. J Inorg Biochem 140:236\u2013244. https:\/\/doi.org\/10.1016\/j.jinorgbio.2014.08.002","journal-title":"J Inorg Biochem"},{"key":"1803_CR31","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jinorgbio.2017.11.013","volume":"179","author":"J Laborde","year":"2018","unstructured":"Laborde J, Deraeve C, de Mesquita Vieira FG, Sournia-Saquet A, Rechignat L, Villela AD, Abbadi BL, Macchi FS, Pissinate K, Bizarro CV, Machado P, Basso LA, Pratviel G, de Franca Lopes LG, Sousa EHS, Bernardes-Genisson V (2018) Synthesis and mechanistic investigation of iron(II) complexes of isoniazid and derivatives as a redox-mediated activation strategy for anti-tuberculosis therapy. J Inorg Biochem 179:71\u201381. https:\/\/doi.org\/10.1016\/j.jinorgbio.2017.11.013","journal-title":"J Inorg Biochem"},{"key":"1803_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.yrtph.2019.104553","volume":"111","author":"VS Rodrigues-Junior","year":"2020","unstructured":"Rodrigues-Junior VS, Villela AD, Abbadi BL, Sperotto NDM, Pissinate K, Picada JN, Bondan da Silva J, Bizarro CV, Machado P, Basso LA (2020) Nonclinical evaluation of IQG-607, an anti-tuberculosis candidate with potential use in combination drug therapy. Regul Toxicol Pharmacol 111:1\u20136. https:\/\/doi.org\/10.1016\/j.yrtph.2019.104553","journal-title":"Regul Toxicol Pharmacol"},{"issue":"5","key":"1803_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0064242","volume":"8","author":"FR Pavan","year":"2013","unstructured":"Pavan FR, Poelhsitz GV, da Cunha LV, Barbosa MI, Leite SR, Batista AA, Cho SH, Franzblau SG, de Camargo MS, Resende FA, Varanda EA, Leite CQ (2013) In vitro and in vivo activities of ruthenium(II) phosphine\/diimine\/picolinate complexes (SCAR) against Mycobacterium tuberculosis. PLoS ONE 8(5):1\u201310. https:\/\/doi.org\/10.1371\/journal.pone.0064242","journal-title":"PLoS ONE"},{"issue":"4","key":"1803_CR34","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s10534-016-9940-6","volume":"29","author":"NH Gama","year":"2016","unstructured":"Gama NH, Elkhadir AY, Gordhan BG, Kana BD, Darkwa J, Meyer D (2016) Activity of phosphino palladium(II) and platinum(II) complexes against HIV-1 and Mycobacterium tuberculosis. Biometals 29(4):637\u2013650. https:\/\/doi.org\/10.1007\/s10534-016-9940-6","journal-title":"Biometals"},{"key":"1803_CR35","unstructured":"WHO (2020) Lack of new antibiotics threatens global efforts to contain drug-resistant infections. https:\/\/www.who.int\/news-room\/detail\/17-01-2020-lack-of-new-antibiotics-threatens-global-efforts-to-contain-drug-resistantinfections. Accessed 28 Mar 2020"},{"issue":"2","key":"1803_CR36","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/nrd3013","volume":"9","author":"DA Rasko","year":"2010","unstructured":"Rasko DA, Sperandio V (2010) Anti-virulence strategies to combat bacteria-mediated disease. Nat Rev Drug Discov 9(2):117\u2013128. https:\/\/doi.org\/10.1038\/nrd3013","journal-title":"Nat Rev Drug Discov"},{"key":"1803_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmicb.2017.01878","volume":"8","author":"S Tiwari","year":"2017","unstructured":"Tiwari S, Jamal SB, Hassan SS, Carvalho P, Almeida S, Barh D, Ghosh P, Silva A, Castro TLP, Azevedo V (2017) Two-component signal transduction systems of pathogenic bacteria as targets for antimicrobial therapy: an overview. Front Microbiol 8:1\u20137. https:\/\/doi.org\/10.3389\/fmicb.2017.01878","journal-title":"Front Microbiol"},{"issue":"1","key":"1803_CR38","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1021\/cb5007135","volume":"10","author":"AE Bem","year":"2015","unstructured":"Bem AE, Velikova N, Pellicer MT, Baarlen P, Marina A, Wells JM (2015) Bacterial histidine kinases as novel antibacterial drug targets. ACS Chem Biol 10(1):213\u2013224. https:\/\/doi.org\/10.1021\/cb5007135","journal-title":"ACS Chem Biol"},{"issue":"4","key":"1803_CR39","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1002\/emmm.200900032","volume":"1","author":"J Njoroge","year":"2009","unstructured":"Njoroge J, Sperandio V (2009) Jamming bacterial communication: new approaches for the treatment of infectious diseases. EMBO Mol Med 1(4):201\u2013210. https:\/\/doi.org\/10.1002\/emmm.200900032","journal-title":"EMBO Mol Med"},{"key":"1803_CR40","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1146\/annurev.micro.091208.073214","volume":"63","author":"R Gao","year":"2009","unstructured":"Gao R, Stock AM (2009) Biological insights from structures of two-component proteins. Annu Rev Microbiol 63:133\u2013154. https:\/\/doi.org\/10.1146\/annurev.micro.091208.073214","journal-title":"Annu Rev Microbiol"},{"issue":"19","key":"1803_CR41","doi-asserted-by":"publisher","first-page":"3752","DOI":"10.1016\/j.jmb.2016.08.003","volume":"428","author":"CP Zschiedrich","year":"2016","unstructured":"Zschiedrich CP, Keidel V, Szurmant H (2016) Molecular mechanisms of two-component signal transduction. J Mol Biol 428(19):3752\u20133775. https:\/\/doi.org\/10.1016\/j.jmb.2016.08.003","journal-title":"J Mol Biol"},{"issue":"37","key":"1803_CR42","doi-asserted-by":"publisher","first-page":"7332","DOI":"10.1039\/c8sc02496k","volume":"9","author":"M Goswami","year":"2018","unstructured":"Goswami M, Espinasse A, Carlson EE (2018) Disarming the virulence arsenal of Pseudomonas aeruginosa by blocking two-component system signaling. Chem Sci 9(37):7332\u20137337. https:\/\/doi.org\/10.1039\/c8sc02496k","journal-title":"Chem Sci"},{"issue":"26","key":"1803_CR43","doi-asserted-by":"publisher","first-page":"10055","DOI":"10.1074\/jbc.RA118.005312","volume":"294","author":"S Singh","year":"2019","unstructured":"Singh S, Goswami N, Tyagi AK, Khare G (2019) Unraveling the role of the transcriptional regulator VirS in low pH-induced responses of Mycobacterium tuberculosis and identification of VirS inhibitors. J Biol Chem 294(26):10055\u201310075. https:\/\/doi.org\/10.1074\/jbc.RA118.005312","journal-title":"J Biol Chem"},{"issue":"2","key":"1803_CR44","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/Nchembio.2259","volume":"13","author":"HQ Zheng","year":"2017","unstructured":"Zheng HQ, Colvin CJ, Johnson BK, Kirchhoff PD, Wilson M, Jorgensen-Muga K, Larsen SD, Abramovitch RB (2017) Inhibitors of Mycobacterium tuberculosis DosRST signaling and persistence. Nat Chem Biol 13(2):218\u2013225. https:\/\/doi.org\/10.1038\/Nchembio.2259","journal-title":"Nat Chem Biol"},{"key":"1803_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2180-14-195","volume":"14","author":"K Kaur","year":"2014","unstructured":"Kaur K, Taneja NK, Dhingra S, Tyagi JS (2014) DevR (DosR) mimetic peptides impair transcriptional regulation and survival of Mycobacterium tuberculosis under hypoxia by inhibiting the autokinase activity of DevS sensor kinase. BMC Microbiol 14:1\u20139. https:\/\/doi.org\/10.1186\/1471-2180-14-195","journal-title":"BMC Microbiol"},{"key":"1803_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep25851","volume":"6","author":"SK Banerjee","year":"2016","unstructured":"Banerjee SK, Kumar M, Alokam R, Sharma AK, Chatterjee A, Kumar R, Sahu SK, Jana K, Singh R, Yogeeswari P, Sriram D, Basu J, Kundu M (2016) Targeting multiple response regulators of Mycobacterium tuberculosis augments the host immune response to infection. Sci Rep 6:1\u201315. https:\/\/doi.org\/10.1038\/srep25851","journal-title":"Sci Rep"},{"issue":"20","key":"1803_CR47","doi-asserted-by":"publisher","first-page":"6324","DOI":"10.1021\/jm900358q","volume":"52","author":"RK Gupta","year":"2009","unstructured":"Gupta RK, Thakur TS, Desiraju GR, Tyagi JS (2009) Structure-based design of DevR inhibitor active against nonreplicating Mycobacterium tuberculosis. J Med Chem 52(20):6324\u20136334. https:\/\/doi.org\/10.1021\/jm900358q","journal-title":"J Med Chem"},{"issue":"3","key":"1803_CR48","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/ja.2016.151","volume":"70","author":"Y Eguchi","year":"2017","unstructured":"Eguchi Y, Okajima T, Tochio N, Inukai Y, Shimizu R, Ueda S, Shinya S, Kigawa T, Fukamizo T, Igarashi M, Utsumi R (2017) Angucycline antibiotic waldiomycin recognizes common structural motif conserved in bacterial histidine kinases. J Antibiot (Tokyo) 70(3):251\u2013258. https:\/\/doi.org\/10.1038\/ja.2016.151","journal-title":"J Antibiot (Tokyo)"},{"issue":"2","key":"1803_CR49","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.nano.2016.09.011","volume":"13","author":"N Velikova","year":"2017","unstructured":"Velikova N, Mas N, Miguel-Romero L, Polo L, Stolte E, Zaccaria E, Cao R, Taverne N, Murguia JR, Martinez-Manez R, Marina A, Wells J (2017) Broadening the antibacterial spectrum of histidine kinase autophosphorylation inhibitors via the use of epsilon-poly-L-lysine capped mesoporous silica-based nanoparticles. Nanomedicine 13(2):569\u2013581. https:\/\/doi.org\/10.1016\/j.nano.2016.09.011","journal-title":"Nanomedicine"},{"issue":"1","key":"1803_CR50","doi-asserted-by":"publisher","first-page":"e01744","DOI":"10.1128\/AAC.01744-19","volume":"64","author":"MA Carabajal","year":"2019","unstructured":"Carabajal MA, Asquith CRM, Laitinen T, Tizzard GJ, Yim L, Rial A, Chabalgoity JA, Zuercher WJ, Garcia Vescovi E (2019) Quinazoline-based anti-virulence compounds selectively target Salmonella PhoP\/PhoQ signal transduction system. Antimicrob Agents Chemother 64(1):e01744\u2013e11719. https:\/\/doi.org\/10.1128\/AAC.01744-19","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"1803_CR51","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1021\/ol036283s","volume":"6","author":"L Zhang","year":"2004","unstructured":"Zhang L, Carroll P, Meggers E (2004) Ruthenium complexes as protein kinase inhibitors. Org Lett 6(4):521\u2013523. https:\/\/doi.org\/10.1021\/ol036283s","journal-title":"Org Lett"},{"issue":"4","key":"1803_CR52","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1021\/acs.chemrev.7b00602","volume":"118","author":"T Yuan","year":"2018","unstructured":"Yuan T, Sampson NS (2018) Hit generation in TB drug discovery: from genome to granuloma. Chem Rev 118(4):1887\u20131916. https:\/\/doi.org\/10.1021\/acs.chemrev.7b00602","journal-title":"Chem Rev"},{"key":"1803_CR53","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/bs.ampbs.2017.05.001","volume":"71","author":"EHS Sousa","year":"2017","unstructured":"Sousa EHS, Gilles-Gonzalez MA (2017) Haem-based sensors of O2: lessons and perspectives. Adv Microb Physiol 71:235\u2013257. https:\/\/doi.org\/10.1016\/bs.ampbs.2017.05.001","journal-title":"Adv Microb Physiol"},{"issue":"1","key":"1803_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jinorgbio.2004.11.006","volume":"99","author":"MA Gilles-Gonzalez","year":"2005","unstructured":"Gilles-Gonzalez MA, Gonzalez G (2005) Heme-based sensors: defining characteristics, recent developments, and regulatory hypotheses. J Inorg Biochem 99(1):1\u201322. https:\/\/doi.org\/10.1016\/j.jinorgbio.2004.11.006","journal-title":"J Inorg Biochem"},{"issue":"13","key":"1803_CR55","doi-asserted-by":"publisher","first-page":"6491","DOI":"10.1021\/acs.chemrev.5b00018","volume":"115","author":"T Shimizu","year":"2015","unstructured":"Shimizu T, Huang D, Yan F, Stranava M, Bartosova M, Fojtikova V, Martinkova M (2015) Gaseous O2, NO, and CO in signal transduction: structure and function relationships of heme-based gas sensors and heme-redox sensors. Chem Rev 115(13):6491\u20136533. https:\/\/doi.org\/10.1021\/acs.chemrev.5b00018","journal-title":"Chem Rev"},{"issue":"6314","key":"1803_CR56","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/350170a0","volume":"350","author":"MA Gilles-Gonzalez","year":"1991","unstructured":"Gilles-Gonzalez MA, Ditta GS, Helinski DR (1991) A haemoprotein with kinase activity encoded by the oxygen sensor of Rhizobium meliloti. Nature 350(6314):170\u2013172. https:\/\/doi.org\/10.1038\/350170a0","journal-title":"Nature"},{"key":"1803_CR57","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jinorgbio.2016.11.022","volume":"167","author":"EH Sousa","year":"2017","unstructured":"Sousa EH, Lopes LG, Gonzalez G, Gilles-Gonzalez MA (2017) Drug discovery targeting heme-based sensors and their coupled activities. J Inorg Biochem 167:12\u201320. https:\/\/doi.org\/10.1016\/j.jinorgbio.2016.11.022","journal-title":"J Inorg Biochem"},{"issue":"5","key":"1803_CR58","doi-asserted-by":"publisher","first-page":"457","DOI":"10.4155\/fmc-2019-0263","volume":"12","author":"H Zheng","year":"2020","unstructured":"Zheng H, Abramovitch RB (2020) Inhibiting DosRST as a new approach to tuberculosis therapy. Future Med Chem 12(5):457\u2013467. https:\/\/doi.org\/10.4155\/fmc-2019-0263","journal-title":"Future Med Chem"},{"key":"1803_CR59","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0076-6879(07)37010-9","volume":"437","author":"MA Gilles-Gonzalez","year":"2008","unstructured":"Gilles-Gonzalez MA, Gonzalez G, Sousa EHS, Tuckerman J (2008) Oxygen-sensing histidine-protein kinases: assays of ligand binding and turnover of response-regulator substrates. Methods Enzymol 437:173\u2013189. https:\/\/doi.org\/10.1016\/S0076-6879(07)37010-9","journal-title":"Methods Enzymol"},{"issue":"8","key":"1803_CR60","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1110\/ps.072897707","volume":"16","author":"EHS Sousa","year":"2007","unstructured":"Sousa EHS, Tuckerman JR, Gonzalez G, Gilles-Gonzalez MA (2007) DosT and DevS are oxygen-switched kinases in Mycobacterium tuberculosis. Protein Sci 16(8):1708\u20131719. https:\/\/doi.org\/10.1110\/ps.072897707","journal-title":"Protein Sci"},{"issue":"3\u20134","key":"1803_CR61","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.tube.2003.12.006","volume":"84","author":"DG Muttucumaru","year":"2004","unstructured":"Muttucumaru DG, Roberts G, Hinds J, Stabler RA, Parish T (2004) Gene expression profile of Mycobacterium tuberculosis in a non-replicating state. Tuberculosis (Edinb) 84(3\u20134):239\u2013246. https:\/\/doi.org\/10.1016\/j.tube.2003.12.006","journal-title":"Tuberculosis (Edinb)"},{"issue":"22","key":"1803_CR62","doi-asserted-by":"publisher","first-page":"23082","DOI":"10.1074\/jbc.M401230200","volume":"279","author":"DM Roberts","year":"2004","unstructured":"Roberts DM, Liao RP, Wisedchaisri G, Hol WG, Sherman DR (2004) Two sensor kinases contribute to the hypoxic response of Mycobacterium tuberculosis. J Biol Chem 279(22):23082\u201323087. https:\/\/doi.org\/10.1074\/jbc.M401230200","journal-title":"J Biol Chem"},{"issue":"22","key":"1803_CR63","doi-asserted-by":"publisher","first-page":"3954","DOI":"10.1111\/febs.14284","volume":"284","author":"EHS Sousa","year":"2017","unstructured":"Sousa EHS, Gonzalez G, Gilles-Gonzalez MA (2017) Target DNA stabilizes Mycobacterium tuberculosis DevR\/DosR phosphorylation by the full-length oxygen sensors DevS\/DosS and DosT. FEBS J 284(22):3954\u20133967. https:\/\/doi.org\/10.1111\/febs.14284","journal-title":"FEBS J"},{"key":"1803_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s42003-019-0594-0","volume":"2","author":"US Gautam","year":"2019","unstructured":"Gautam US, Mehra S, Kumari P, Alvarez X, Niu T, Tyagi JS, Kaushal D (2019) Mycobacterium tuberculosis sensor kinase DosS modulates the autophagosome in a DosR-independent manner. Commun Biol 2:1\u201312. https:\/\/doi.org\/10.1038\/s42003-019-0594-0","journal-title":"Commun Biol"},{"issue":"10","key":"1803_CR65","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1164\/rccm.201408-1502OC","volume":"191","author":"S Mehra","year":"2015","unstructured":"Mehra S, Foreman TW, Didier PJ, Ahsan MH, Hudock TA, Kissee R, Golden NA, Gautam US, Johnson AM, Alvarez X, Russell-Lodrigue KE, Doyle LA, Roy CJ, Niu T, Blanchard JL, Khader SA, Lackner AA, Sherman DR, Kaushal D (2015) The DosR regulon modulates adaptive immunity and is essential for Mycobacterium tuberculosis Persistence. Am J Respir Crit Care Med 191(10):1185\u20131196. https:\/\/doi.org\/10.1164\/rccm.201408-1502OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"1803_CR66","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1128\/IAI.01117-08","volume":"77","author":"PJ Converse","year":"2009","unstructured":"Converse PJ, Karakousis PC, Klinkenberg LG, Kesavan AK, Ly LH, Allen SS, Grosset JH, Jain SK, Lamichhane G, Manabe YC, McMurray DN, Nuermberger EL, Bishai WR (2009) Role of the dosR-dosS two-component regulatory system in Mycobacterium tuberculosis virulence in three animal models. Infect Immun 77(3):1230\u20131237. https:\/\/doi.org\/10.1128\/IAI.01117-08","journal-title":"Infect Immun"},{"issue":"1","key":"1803_CR67","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/j.1574-6968.2012.02534.x","volume":"330","author":"S Dhingra","year":"2012","unstructured":"Dhingra S, Kaur K, Taneja NK, Tyagi JS (2012) DevR (DosR) binding peptide inhibits adaptation of Mycobacterium tuberculosis under hypoxia. Fems Microbiol Lett 330(1):66\u201371. https:\/\/doi.org\/10.1111\/j.1574-6968.2012.02534.x","journal-title":"Fems Microbiol Lett"},{"issue":"1","key":"1803_CR68","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1021\/acschembio.8b00849","volume":"15","author":"H Zheng","year":"2020","unstructured":"Zheng H, Williams JT, Aleiwi B, Ellsworth E, Abramovitch RB (2020) Inhibiting Mycobacterium tuberculosis DosRST signaling by targeting response regulator DNA binding and sensor kinase heme. ACS Chem Biol 15(1):52\u201362. https:\/\/doi.org\/10.1021\/acschembio.8b00849","journal-title":"ACS Chem Biol"},{"key":"1803_CR69","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.tube.2019.03.004","volume":"115","author":"YS Patel","year":"2019","unstructured":"Patel YS, Mistry N, Mehra S (2019) Repurposing artemisinin as an anti-mycobacterial agent in synergy with rifampicin. Tuberculosis (Edinb) 115:146\u2013153. https:\/\/doi.org\/10.1016\/j.tube.2019.03.004","journal-title":"Tuberculosis (Edinb)"},{"issue":"21","key":"1803_CR70","doi-asserted-by":"publisher","first-page":"4278","DOI":"10.1111\/febs.14974","volume":"286","author":"GA Barreto","year":"2019","unstructured":"Barreto GA, Carepo MSP, Gondim ACS, Guimaraes WG, Lopes LGF, Bernhardt PV, Paulo TF, Sousa EHS, Diogenes ICN (2019) A spectroelectrochemical investigation of the heme-based sensor DevS from Mycobacterium tuberculosis: a redox versus oxygen sensor. FEBS J 286(21):4278\u20134293. https:\/\/doi.org\/10.1111\/febs.14974","journal-title":"FEBS J"},{"issue":"22","key":"1803_CR71","doi-asserted-by":"crossref","first-page":"16293","DOI":"10.1016\/S0021-9258(19)85419-4","volume":"268","author":"MA Gilles-Gonzalez","year":"1993","unstructured":"Gilles-Gonzalez MA, Gonzalez G (1993) Regulation of the kinase activity of heme protein FixL from the two-component system FixL\/FixJ of Rhizobium meliloti. J Biol Chem 268(22):16293\u201316297","journal-title":"J Biol Chem"},{"issue":"2","key":"1803_CR72","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.cbpa.2012.11.015","volume":"17","author":"C Gwizdala","year":"2013","unstructured":"Gwizdala C, Burdette SC (2013) Following the Ca(2)(+) roadmap to photocaged complexes for Zn(2)(+) and beyond. Curr Opin Chem Biol 17(2):137\u2013142. https:\/\/doi.org\/10.1016\/j.cbpa.2012.11.015","journal-title":"Curr Opin Chem Biol"},{"issue":"7","key":"1803_CR73","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1039\/c8mt00067k","volume":"10","author":"EG Salina","year":"2018","unstructured":"Salina EG, Huszar S, Zemanova J, Keruchenko J, Riabova O, Kazakova E, Grigorov A, Azhikina T, Kaprelyants A, Mikusova K, Makarov V (2018) Copper-related toxicity in replicating and dormant Mycobacterium tuberculosis caused by 1-hydroxy-5-R-pyridine-2(1H)-thiones. Metallomics 10(7):992\u20131002. https:\/\/doi.org\/10.1039\/c8mt00067k","journal-title":"Metallomics"},{"issue":"1","key":"1803_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/microbiolspec.MGM2-0010-2013","volume":"2","author":"T Parish","year":"2014","unstructured":"Parish T (2014) Two-component regulatory systems of Mycobacteria. Microbiol Spectr 2(1):1\u201314. https:\/\/doi.org\/10.1128\/microbiolspec.MGM2-0010-2013","journal-title":"Microbiol Spectr"},{"issue":"3","key":"1803_CR75","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1111\/j.1365-2958.2006.05137.x","volume":"60","author":"M Fol","year":"2006","unstructured":"Fol M, Chauhan A, Nair NK, Maloney E, Moomey M, Jagannath C, Madiraju MV, Rajagopalan M (2006) Modulation of Mycobacterium tuberculosis proliferation by MtrA, an essential two-component response regulator. Mol Microbiol 60(3):643\u2013657. https:\/\/doi.org\/10.1111\/j.1365-2958.2006.05137.x","journal-title":"Mol Microbiol"},{"key":"1803_CR76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12866-014-0265-8","volume":"14","author":"D Rifat","year":"2014","unstructured":"Rifat D, Belchis DA, Karakousis PC (2014) SenX3-independent contribution of RegX3 to Mycobacterium tuberculosis virulence. BMC Microbiol 14:1\u201312. https:\/\/doi.org\/10.1186\/s12866-014-0265-8","journal-title":"BMC Microbiol"},{"issue":"3","key":"1803_CR77","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1111\/mmi.13332","volume":"100","author":"SR Elliott","year":"2016","unstructured":"Elliott SR, Tischler AD (2016) Phosphate starvation: a novel signal that triggers ESX-5 secretion in Mycobacterium tuberculosis. Mol Microbiol 100(3):510\u2013526. https:\/\/doi.org\/10.1111\/mmi.13332","journal-title":"Mol Microbiol"},{"issue":"12","key":"1803_CR78","doi-asserted-by":"publisher","first-page":"6962","DOI":"10.1128\/iai.71.12.6962-6970.2003","volume":"71","author":"TC Zahrt","year":"2003","unstructured":"Zahrt TC, Wozniak C, Jones D, Trevett A (2003) Functional analysis of the Mycobacterium tuberculosis MprAB two-component signal transduction system. Infect Immun 71(12):6962\u20136970. https:\/\/doi.org\/10.1128\/iai.71.12.6962-6970.2003","journal-title":"Infect Immun"},{"issue":"22","key":"1803_CR79","doi-asserted-by":"publisher","first-page":"12706","DOI":"10.1073\/pnas.221272198","volume":"98","author":"TC Zahrt","year":"2001","unstructured":"Zahrt TC, Deretic V (2001) Mycobacterium tuberculosis signal transduction system required for persistent infections. Proc Natl Acad Sci U S A 98(22):12706\u201312711. https:\/\/doi.org\/10.1073\/pnas.221272198","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"1803_CR80","doi-asserted-by":"publisher","first-page":"2900","DOI":"10.1128\/jb.179.9.2900-2906.1997","volume":"179","author":"P Lefevre","year":"1997","unstructured":"Lefevre P, Braibant M, de Wit L, Kalai M, Roeper D, Grotzinger J, Delville JP, Peirs P, Ooms J, Huygen K, Content J (1997) Three different putative phosphate transport receptors are encoded by the Mycobacterium tuberculosis genome and are present at the surface of Mycobacterium bovis BCG. J Bacteriol 179(9):2900\u20132906. https:\/\/doi.org\/10.1128\/jb.179.9.2900-2906.1997","journal-title":"J Bacteriol"},{"issue":"16","key":"1803_CR81","doi-asserted-by":"publisher","first-page":"4983","DOI":"10.1128\/jb.185.16.4983-4991.2003","volume":"185","author":"J Kriakov","year":"2003","unstructured":"Kriakov J, Lee S, Jacobs WR Jr (2003) Identification of a regulated alkaline phosphatase, a cell surface-associated lipoprotein, in Mycobacterium smegmatis. J Bacteriol 185(16):4983\u20134991. https:\/\/doi.org\/10.1128\/jb.185.16.4983-4991.2003","journal-title":"J Bacteriol"},{"issue":"15","key":"1803_CR82","doi-asserted-by":"publisher","first-page":"5495","DOI":"10.1128\/JB.00190-07","volume":"189","author":"RT Glover","year":"2007","unstructured":"Glover RT, Kriakov J, Garforth SJ, Baughn AD, Jacobs WR Jr (2007) The two-component regulatory system senX3-regX3 regulates phosphate-dependent gene expression in Mycobacterium smegmatis. J Bacteriol 189(15):5495\u20135503. https:\/\/doi.org\/10.1128\/JB.00190-07","journal-title":"J Bacteriol"},{"issue":"7","key":"1803_CR83","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1089\/ars.2014.6020","volume":"22","author":"N Singh","year":"2015","unstructured":"Singh N, Kumar A (2015) Virulence factor SenX3 is the oxygen-controlled replication switch of Mycobacterium tuberculosis. Antioxid Redox Signal 22(7):603\u2013613. https:\/\/doi.org\/10.1089\/ars.2014.6020","journal-title":"Antioxid Redox Signal"},{"issue":"7","key":"1803_CR84","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1086\/605700","volume":"200","author":"D Rifat","year":"2009","unstructured":"Rifat D, Bishai WR, Karakousis PC (2009) Phosphate depletion: a novel trigger for Mycobacterium tuberculosis persistence. J Infect Dis 200(7):1126\u20131135. https:\/\/doi.org\/10.1086\/605700","journal-title":"J Infect Dis"},{"issue":"5","key":"1803_CR85","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1084\/jem.20040646","volume":"200","author":"PC Karakousis","year":"2004","unstructured":"Karakousis PC, Yoshimatsu T, Lamichhane G, Woolwine SC, Nuermberger EL, Grosset J, Bishai WR (2004) Dormancy phenotype displayed by extracellular Mycobacterium tuberculosis within artificial granulomas in mice. J Exp Med 200(5):647\u2013657. https:\/\/doi.org\/10.1084\/jem.20040646","journal-title":"J Exp Med"},{"issue":"9","key":"1803_CR86","doi-asserted-by":"publisher","first-page":"3018","DOI":"10.1128\/IAI.00520-12","volume":"80","author":"DJ Bretl","year":"2012","unstructured":"Bretl DJ, He H, Demetriadou C, White MJ, Penoske RM, Salzman NH, Zahrt TC (2012) MprA and DosR coregulate a Mycobacterium tuberculosis virulence operon encoding Rv1813c and Rv1812c. Infect Immun 80(9):3018\u20133033. https:\/\/doi.org\/10.1128\/IAI.00520-12","journal-title":"Infect Immun"},{"issue":"19","key":"1803_CR87","doi-asserted-by":"publisher","first-page":"5105","DOI":"10.1128\/JB.05562-11","volume":"193","author":"H He","year":"2011","unstructured":"He H, Bretl DJ, Penoske RM, Anderson DM, Zahrt TC (2011) Components of the Rv0081-Rv0088 locus, which encodes a predicted formate hydrogenlyase complex, are coregulated by Rv0081, MprA, and DosR in Mycobacterium tuberculosis. J Bacteriol 193(19):5105\u20135118. https:\/\/doi.org\/10.1128\/JB.05562-11","journal-title":"J Bacteriol"},{"issue":"17","key":"1803_CR88","doi-asserted-by":"publisher","first-page":"4889","DOI":"10.1128\/jb.182.17.4889-4898.2000","volume":"182","author":"TP Primm","year":"2000","unstructured":"Primm TP, Andersen SJ, Mizrahi V, Avarbock D, Rubin H, Barry CE 3rd (2000) The stringent response of Mycobacterium tuberculosis is required for long-term survival. J Bacteriol 182(17):4889\u20134898. https:\/\/doi.org\/10.1128\/jb.182.17.4889-4898.2000","journal-title":"J Bacteriol"},{"issue":"3","key":"1803_CR89","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/sciadv.aav2104","volume":"5","author":"NK Dutta","year":"2019","unstructured":"Dutta NK, Klinkenberg LG, Vazquez MJ, Segura-Carro D, Colmenarejo G, Ramon F, Rodriguez-Miquel B, Mata-Cantero L, Porras-De Francisco E, Chuang YM, Rubin H, Lee JJ, Eoh H, Bader JS, Perez-Herran E, Mendoza-Losana A, Karakousis PC (2019) Inhibiting the stringent response blocks Mycobacterium tuberculosis entry into quiescence and reduces persistence. Sci Adv 5(3):1\u201313. https:\/\/doi.org\/10.1126\/sciadv.aav2104","journal-title":"Sci Adv"},{"issue":"4","key":"1803_CR90","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1007\/s12539-014-0179-z","volume":"6","author":"KV Shivakumar","year":"2014","unstructured":"Shivakumar KV, Karunakar P, Chatterjee J (2014) Inhibition of NarL of Mycobacterium tuberculosis: an in silico approach. Interdiscip Sci 6(4):292\u2013299. https:\/\/doi.org\/10.1007\/s12539-014-0179-z","journal-title":"Interdiscip Sci"},{"key":"1803_CR91","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2019.1657499","author":"N Kumar","year":"2019","unstructured":"Kumar N, Srivastava R, Prakash A, Lynn AM (2019) Structure-based virtual screening, molecular dynamics simulation and MM-PBSA toward identifying the inhibitors for two-component regulatory system protein NarL of Mycobacterium tuberculosis. J Biomol Struct Dyn. https:\/\/doi.org\/10.1080\/07391102.2019.1657499","journal-title":"J Biomol Struct Dyn"},{"issue":"10","key":"1803_CR92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0003496","volume":"3","author":"J Gonzalo-Asensio","year":"2008","unstructured":"Gonzalo-Asensio J, Mostowy S, Harders-Westerveen J, Huygen K, Hernandez-Pando R, Thole J, Behr M, Gicquel B, Martin C (2008) PhoP: a missing piece in the intricate puzzle of Mycobacterium tuberculosis virulence. PLoS ONE 3(10):1\u201311. https:\/\/doi.org\/10.1371\/journal.pone.0003496","journal-title":"PLoS ONE"},{"issue":"8","key":"1803_CR93","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/JB.00766-17","volume":"200","author":"L Feng","year":"2018","unstructured":"Feng L, Chen S, Hu Y (2018) PhoPR positively regulates whiB3 expression in response to low pH in pathogenic Mycobacteria. J Bacteriol 200(8):1\u201311. https:\/\/doi.org\/10.1128\/JB.00766-17","journal-title":"J Bacteriol"},{"issue":"2","key":"1803_CR94","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/j.1365-2958.2007.05819.x","volume":"65","author":"R Manganelli","year":"2007","unstructured":"Manganelli R (2007) Polyphosphate and stress response in mycobacteria. Mol Microbiol 65(2):258\u2013260. https:\/\/doi.org\/10.1111\/j.1365-2958.2007.05819.x","journal-title":"Mol Microbiol"},{"issue":"9","key":"1803_CR95","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11274-018-2523-7","volume":"34","author":"T Kulakovskaya","year":"2018","unstructured":"Kulakovskaya T (2018) Inorganic polyphosphates and heavy metal resistance in microorganisms. World J Microbiol Biotechnol 34(9):1\u20138. https:\/\/doi.org\/10.1007\/s11274-018-2523-7","journal-title":"World J Microbiol Biotechnol"},{"issue":"9","key":"1803_CR96","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1021\/acsinfecdis.9b00204","volume":"5","author":"JK Hobbs","year":"2019","unstructured":"Hobbs JK, Boraston AB (2019) (p)ppGpp and the stringent response: an emerging threat to antibiotic therapy. ACS Infect Dis 5(9):1505\u20131517. https:\/\/doi.org\/10.1021\/acsinfecdis.9b00204","journal-title":"ACS Infect Dis"},{"issue":"17","key":"1803_CR97","doi-asserted-by":"publisher","first-page":"10026","DOI":"10.1073\/pnas.1631248100","volume":"100","author":"JL Dahl","year":"2003","unstructured":"Dahl JL, Kraus CN, Boshoff HI, Doan B, Foley K, Avarbock D, Kaplan G, Mizrahi V, Rubin H, Barry CE 3rd (2003) The role of RelMtb-mediated adaptation to stationary phase in long-term persistence of Mycobacterium tuberculosis in mice. Proc Natl Acad Sci USA 100(17):10026\u201310031. https:\/\/doi.org\/10.1073\/pnas.1631248100","journal-title":"Proc Natl Acad Sci USA"},{"issue":"28","key":"1803_CR98","doi-asserted-by":"publisher","first-page":"10819","DOI":"10.1074\/jbc.RA119.008370","volume":"294","author":"P Tiwari","year":"2019","unstructured":"Tiwari P, Gosain TP, Singh M, Sankhe GD, Arora G, Kidwai S, Agarwal S, Chugh S, Saini DK, Singh R (2019) Inorganic polyphosphate accumulation suppresses the dormancy response and virulence in Mycobacterium tuberculosis. J Biol Chem 294(28):10819\u201310832. https:\/\/doi.org\/10.1074\/jbc.RA119.008370","journal-title":"J Biol Chem"},{"issue":"12","key":"1803_CR99","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.1128\/JB.00038-13","volume":"195","author":"R Singh","year":"2013","unstructured":"Singh R, Singh M, Arora G, Kumar S, Tiwari P, Kidwai S (2013) Polyphosphate deficiency in Mycobacterium tuberculosis is associated with enhanced drug susceptibility and impaired growth in guinea pigs. J Bacteriol 195(12):2839\u20132851. https:\/\/doi.org\/10.1128\/JB.00038-13","journal-title":"J Bacteriol"},{"issue":"2","key":"1803_CR100","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/j.1365-2958.2007.05814.x","volume":"65","author":"K Sureka","year":"2007","unstructured":"Sureka K, Dey S, Datta P, Singh AK, Dasgupta A, Rodrigue S, Basu J, Kundu M (2007) Polyphosphate kinase is involved in stress-induced mprAB-sigE-rel signalling in mycobacteria. Mol Microbiol 65(2):261\u2013276. https:\/\/doi.org\/10.1111\/j.1365-2958.2007.05814.x","journal-title":"Mol Microbiol"},{"issue":"5","key":"1803_CR101","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1111\/j.1365-2958.2009.06925.x","volume":"74","author":"K Sureka","year":"2009","unstructured":"Sureka K, Sanyal S, Basu J, Kundu M (2009) Polyphosphate kinase 2: a modulator of nucleoside diphosphate kinase activity in mycobacteria. Mol Microbiol 74(5):1187\u20131197. https:\/\/doi.org\/10.1111\/j.1365-2958.2009.06925.x","journal-title":"Mol Microbiol"},{"key":"1803_CR102","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep26900","volume":"6","author":"M Singh","year":"2016","unstructured":"Singh M, Tiwari P, Arora G, Agarwal S, Kidwai S, Singh R (2016) Establishing virulence associated polyphosphate kinase 2 as a drug target for Mycobacterium tuberculosis. Sci Rep 6:1\u201313. https:\/\/doi.org\/10.1038\/srep26900","journal-title":"Sci Rep"},{"issue":"11","key":"1803_CR103","doi-asserted-by":"publisher","first-page":"e28076","DOI":"10.1371\/journal.pone.0028076","volume":"6","author":"SM Thayil","year":"2011","unstructured":"Thayil SM, Morrison N, Schechter N, Rubin H, Karakousis PC (2011) The role of the novel exopolyphosphatase MT0516 in Mycobacterium tuberculosis drug tolerance and persistence. PLoS ONE 6(11):e28076. https:\/\/doi.org\/10.1371\/journal.pone.0028076","journal-title":"PLoS ONE"},{"issue":"15","key":"1803_CR104","doi-asserted-by":"publisher","first-page":"3261","DOI":"10.1021\/bi2001455","volume":"50","author":"KT Shum","year":"2011","unstructured":"Shum KT, Lui EL, Wong SC, Yeung P, Sam L, Wang Y, Watt RM, Tanner JA (2011) Aptamer-mediated inhibition of Mycobacterium tuberculosis polyphosphate kinase 2. Biochemistry 50(15):3261\u20133271. https:\/\/doi.org\/10.1021\/bi2001455","journal-title":"Biochemistry"},{"issue":"6","key":"1803_CR105","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1111\/cbdd.13439","volume":"93","author":"M Burda-Grabowska","year":"2019","unstructured":"Burda-Grabowska M, Macegoniuk K, Flick R, Nocek BP, Joachimiak A, Yakunin AF, Mucha A, Berlicki L (2019) Bisphosphonic acids and related compounds as inhibitors of nucleotide- and polyphosphate-processing enzymes: A PPK1 and PPK2 case study. Chem Biol Drug Des 93(6):1197\u20131206. https:\/\/doi.org\/10.1111\/cbdd.13439","journal-title":"Chem Biol Drug Des"},{"issue":"9","key":"1803_CR106","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1086\/656524","volume":"202","author":"LG Klinkenberg","year":"2010","unstructured":"Klinkenberg LG, Lee JH, Bishai WR, Karakousis PC (2010) The stringent response is required for full virulence of Mycobacterium tuberculosis in guinea pigs. J Infect Dis 202(9):1397\u20131404. https:\/\/doi.org\/10.1086\/656524","journal-title":"J Infect Dis"},{"key":"1803_CR107","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.biochi.2019.07.006","volume":"165","author":"GS Kushwaha","year":"2019","unstructured":"Kushwaha GS, Oyeyemi BF, Bhavesh NS (2019) Stringent response protein as a potential target to intervene persistent bacterial infection. Biochimie 165:67\u201375. https:\/\/doi.org\/10.1016\/j.biochi.2019.07.006","journal-title":"Biochimie"},{"issue":"6","key":"1803_CR108","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/AAC.00443-17","volume":"61","author":"K Syal","year":"2017","unstructured":"Syal K, Flentie K, Bhardwaj N, Maiti K, Jayaraman N, Stallings CL, Chatterji D (2017) Synthetic (p)ppGpp analogue is an inhibitor of stringent response in Mycobacteria. Antimicrob Agents Chemother 61(6):1\u201314. https:\/\/doi.org\/10.1128\/AAC.00443-17","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"1803_CR109","doi-asserted-by":"publisher","first-page":"e1002925","DOI":"10.1371\/journal.ppat.1002925","volume":"8","author":"E Wexselblatt","year":"2012","unstructured":"Wexselblatt E, Oppenheimer-Shaanan Y, Kaspy I, London N, Schueler-Furman O, Yavin E, Glaser G, Katzhendler J, Ben-Yehuda S (2012) Relacin, a novel antibacterial agent targeting the stringent response. PLoS Pathog 8(9):e1002925. https:\/\/doi.org\/10.1371\/journal.ppat.1002925","journal-title":"PLoS Pathog"},{"key":"1803_CR110","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.ejmech.2013.10.036","volume":"70","author":"E Wexselblatt","year":"2013","unstructured":"Wexselblatt E, Kaspy I, Glaser G, Katzhendler J, Yavin E (2013) Design, synthesis and structure-activity relationship of novel Relacin analogs as inhibitors of Rel proteins. Eur J Med Chem 70:497\u2013504. https:\/\/doi.org\/10.1016\/j.ejmech.2013.10.036","journal-title":"Eur J Med Chem"},{"issue":"38","key":"1803_CR111","doi-asserted-by":"publisher","first-page":"11640","DOI":"10.1021\/bi001256k","volume":"39","author":"D Avarbock","year":"2000","unstructured":"Avarbock D, Avarbock A, Rubin H (2000) Differential regulation of opposing RelMtb activities by the aminoacylation state of a tRNA.ribosome.mRNA.RelMtb complex. Biochemistry 39(38):11640\u201311648. https:\/\/doi.org\/10.1021\/bi001256k","journal-title":"Biochemistry"},{"issue":"48","key":"1803_CR112","doi-asserted-by":"publisher","first-page":"34977","DOI":"10.1074\/jbc.M704828200","volume":"282","author":"M Sajish","year":"2007","unstructured":"Sajish M, Tiwari D, Rananaware D, Nandicoori VK, Prakash B (2007) A charge reversal differentiates (p)ppGpp synthesis by monofunctional and bifunctional Rel proteins. J Biol Chem 282(48):34977\u201334983. https:\/\/doi.org\/10.1074\/jbc.M704828200","journal-title":"J Biol Chem"},{"issue":"9","key":"1803_CR113","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1002\/iub.1871","volume":"70","author":"MZ Khan","year":"2018","unstructured":"Khan MZ, Kaur P, Nandicoori VK (2018) Targeting the messengers: serine\/threonine protein kinases as potential targets for antimycobacterial drug development. IUBMB Life 70(9):889\u2013904. https:\/\/doi.org\/10.1002\/iub.1871","journal-title":"IUBMB Life"},{"issue":"5","key":"1803_CR114","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/s41435-019-0069-9","volume":"20","author":"M Bellinzoni","year":"2019","unstructured":"Bellinzoni M, Wehenkel AM, Duran R, Alzari PM (2019) Novel mechanistic insights into physiological signaling pathways mediated by mycobacterial Ser\/Thr protein kinases. Genes Immun 20(5):383\u2013393. https:\/\/doi.org\/10.1038\/s41435-019-0069-9","journal-title":"Genes Immun"},{"issue":"3","key":"1803_CR115","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1042\/BST20160327","volume":"45","author":"MJ Knape","year":"2017","unstructured":"Knape MJ, Herberg FW (2017) Metal coordination in kinases and pseudokinases. Biochem Soc Trans 45(3):653\u2013663. https:\/\/doi.org\/10.1042\/BST20160327","journal-title":"Biochem Soc Trans"},{"issue":"3","key":"1803_CR116","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/nsb897","volume":"10","author":"TA Young","year":"2003","unstructured":"Young TA, Delagoutte B, Endrizzi JA, Falick AM, Alber T (2003) Structure of Mycobacterium tuberculosis PknB supports a universal activation mechanism for Ser\/Thr protein kinases. Nat Struct Biol 10(3):168\u2013174. https:\/\/doi.org\/10.1038\/nsb897","journal-title":"Nat Struct Biol"},{"issue":"9","key":"1803_CR117","doi-asserted-by":"publisher","first-page":"632","DOI":"10.14348\/molcells.2017.0076","volume":"40","author":"HJ Bae","year":"2017","unstructured":"Bae HJ, Lee HN, Baek MN, Park EJ, Eom CY, Ko IJ, Kang HY, Oh JI (2017) Inhibition of the DevSR Two-component system by overexpression of Mycobacterium tuberculosis PknB in Mycobacterium smegmatis. Mol Cells 40(9):632\u2013642. https:\/\/doi.org\/10.14348\/molcells.2017.0076","journal-title":"Mol Cells"},{"issue":"9","key":"1803_CR118","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1002\/iub.1863","volume":"70","author":"R Dhiman","year":"2018","unstructured":"Dhiman R, Singh R (2018) Recent advances for identification of new scaffolds and drug targets for Mycobacterium tuberculosis. IUBMB Life 70(9):905\u2013916. https:\/\/doi.org\/10.1002\/iub.1863","journal-title":"IUBMB Life"},{"issue":"2","key":"1803_CR119","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/mBio.02333-17","volume":"9","author":"X Carette","year":"2018","unstructured":"Carette X, Platig J, Young DC, Helmel M, Young AT, Wang Z, Potluri LP, Moody CS, Zeng J, Prisic S, Paulson JN, Muntel J, Madduri AVR, Velarde J, Mayfield JA, Locher C, Wang T, Quackenbush J, Rhee KY, Moody DB, Steen H, Husson RN (2018) Multisystem analysis of Mycobacterium tuberculosis reveals kinase-dependent remodeling of the pathogen-environment interface. MBio 9(2):1\u201321. https:\/\/doi.org\/10.1128\/mBio.02333-17","journal-title":"MBio"},{"issue":"1","key":"1803_CR120","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12941-017-0234-9","volume":"16","author":"A Gupta","year":"2017","unstructured":"Gupta A, Pal SK, Pandey D, Fakir NA, Rathod S, Sinha D, SivaKumar S, Sinha P, Periera M, Balgam S, Sekar G, UmaDevi KR, Anupurba S, Nema V (2017) PknB remains an essential and a conserved target for drug development in susceptible and MDR strains of M. Tuberculosis. Ann Clin Microbiol Antimicrob 16(1):1\u201310. https:\/\/doi.org\/10.1186\/s12941-017-0234-9","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"1","key":"1803_CR121","doi-asserted-by":"publisher","first-page":"e1001746","DOI":"10.1371\/journal.pbio.1001746","volume":"12","author":"C Ortega","year":"2014","unstructured":"Ortega C, Liao R, Anderson LN, Rustad T, Ollodart AR, Wright AT, Sherman DR, Grundner C (2014) Mycobacterium tuberculosis Ser\/Thr protein kinase B mediates an oxygen-dependent replication switch. PLoS Biol 12(1):e1001746. https:\/\/doi.org\/10.1371\/journal.pbio.1001746","journal-title":"PLoS Biol"},{"issue":"2","key":"1803_CR122","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.imlet.2007.12.005","volume":"116","author":"R Szekely","year":"2008","unstructured":"Szekely R, Waczek F, Szabadkai I, Nemeth G, Hegymegi-Barakonyi B, Eros D, Szokol B, Pato J, Hafenbradl D, Satchell J, Saint-Joanis B, Cole ST, Orfi L, Klebl BM, Keri G (2008) A novel drug discovery concept for tuberculosis: inhibition of bacterial and host cell signalling. Immunol Lett 116(2):225\u2013231. https:\/\/doi.org\/10.1016\/j.imlet.2007.12.005","journal-title":"Immunol Lett"},{"issue":"4","key":"1803_CR123","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.tube.2011.03.005","volume":"91","author":"KE Lougheed","year":"2011","unstructured":"Lougheed KE, Osborne SA, Saxty B, Whalley D, Chapman T, Bouloc N, Chugh J, Nott TJ, Patel D, Spivey VL, Kettleborough CA, Bryans JS, Taylor DL, Smerdon SJ, Buxton RS (2011) Effective inhibitors of the essential kinase PknB and their potential as anti-mycobacterial agents. Tuberculosis (Edinb) 91(4):277\u2013286. https:\/\/doi.org\/10.1016\/j.tube.2011.03.005","journal-title":"Tuberculosis (Edinb)"},{"issue":"9","key":"1803_CR124","doi-asserted-by":"publisher","first-page":"3349","DOI":"10.1016\/j.bmcl.2012.02.107","volume":"22","author":"TM Chapman","year":"2012","unstructured":"Chapman TM, Bouloc N, Buxton RS, Chugh J, Lougheed KE, Osborne SA, Saxty B, Smerdon SJ, Taylor DL, Whalley D (2012) Substituted aminopyrimidine protein kinase B (PknB) inhibitors show activity against Mycobacterium tuberculosis. Bioorg Med Chem Lett 22(9):3349\u20133353. https:\/\/doi.org\/10.1016\/j.bmcl.2012.02.107","journal-title":"Bioorg Med Chem Lett"},{"issue":"12","key":"1803_CR125","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1021\/acsmedchemlett.7b00239","volume":"8","author":"T Wang","year":"2017","unstructured":"Wang T, Bemis G, Hanzelka B, Zuccola H, Wynn M, Moody CS, Green J, Locher C, Liu A, Gao H, Xu Y, Wang S, Wang J, Bennani YL, Thomson JA, Muh U (2017) Mtb PknA\/PknB dual inhibition provides selectivity advantages for inhibitor design to minimize host kinase interactions. ACS Med Chem Lett 8(12):1224\u20131229. https:\/\/doi.org\/10.1021\/acsmedchemlett.7b00239","journal-title":"ACS Med Chem Lett"},{"issue":"11","key":"1803_CR126","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.1021\/mp300269g","volume":"9","author":"RK Verma","year":"2012","unstructured":"Verma RK, Singh AK, Mohan M, Agrawal AK, Verma PR, Gupta A, Misra A (2012) Inhalable microparticles containing nitric oxide donors: saying NO to intracellular Mycobacterium tuberculosis. Mol Pharm 9(11):3183\u20133189. https:\/\/doi.org\/10.1021\/mp300269g","journal-title":"Mol Pharm"},{"issue":"7","key":"1803_CR127","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1039\/c8bm00282g","volume":"6","author":"FY Su","year":"2018","unstructured":"Su FY, Chen J, Son HN, Kelly AM, Convertine AJ, West TE, Skerrett SJ, Ratner DM, Stayton PS (2018) Polymer-augmented liposomes enhancing antibiotic delivery against intracellular infections. Biomater Sci 6(7):1976\u20131985. https:\/\/doi.org\/10.1039\/c8bm00282g","journal-title":"Biomater Sci"},{"key":"1803_CR128","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.tube.2017.10.005","volume":"108","author":"VS Bais","year":"2018","unstructured":"Bais VS, Mohapatra B, Ahamad N, Boggaram S, Verma S, Prakash B (2018) Investigating the inhibitory potential of 2-Aminopurine metal complexes against serine\/threonine protein kinases from Mycobacterium tuberculosis. Tuberculosis (Edinb) 108:47\u201355. https:\/\/doi.org\/10.1016\/j.tube.2017.10.005","journal-title":"Tuberculosis (Edinb)"},{"key":"1803_CR129","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmicb.2018.00880","volume":"9","author":"BL Abbadi","year":"2018","unstructured":"Abbadi BL, Rodrigues-Junior VDS, Dadda ADS, Pissinate K, Villela AD, Campos MM, Lopes LGF, Bizarro CV, Machado P, Sousa EHS, Basso LA (2018) Is IQG-607 a potential metallodrug or metallopro-drug with a defined molecular target in Mycobacterium tuberculosis? Front Microbiol 9:1\u201321. https:\/\/doi.org\/10.3389\/fmicb.2018.00880","journal-title":"Front Microbiol"},{"issue":"45","key":"1803_CR130","doi-asserted-by":"publisher","first-page":"5106","DOI":"10.1039\/c3cc41143e","volume":"49","author":"NP Barry","year":"2013","unstructured":"Barry NP, Sadler PJ (2013) Exploration of the medical periodic table: towards new targets. Chem Commun (Camb) 49(45):5106\u20135131. https:\/\/doi.org\/10.1039\/c3cc41143e","journal-title":"Chem Commun (Camb)"},{"issue":"2","key":"1803_CR131","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s00775-014-1234-2","volume":"20","author":"LB Maia","year":"2015","unstructured":"Maia LB, Moura JJ (2015) Nitrite reduction by molybdoenzymes: a new class of nitric oxide-forming nitrite reductases. J Biol Inorg Chem 20(2):403\u2013433. https:\/\/doi.org\/10.1007\/s00775-014-1234-2","journal-title":"J Biol Inorg Chem"},{"issue":"2\u20133","key":"1803_CR132","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.micpath.2006.04.006","volume":"41","author":"A Khan","year":"2006","unstructured":"Khan A, Sarkar D (2006) Identification of a respiratory-type nitrate reductase and its role for survival of Mycobacterium smegmatis in Wayne model. Microb Pathogenesis 41(2\u20133):90\u201395. https:\/\/doi.org\/10.1016\/j.micpath.2006.04.006","journal-title":"Microb Pathogenesis"},{"issue":"2","key":"1803_CR133","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1111\/1462-2920.13062","volume":"18","author":"C Bardon","year":"2016","unstructured":"Bardon C, Piola F, Haichar Fel Z, Meiffren G, Comte G, Missery B, Balby M, Poly F (2016) Identification of B-type procyanidins in Fallopia spp. involved in biological denitrification inhibition. Environ Microbiol 18(2):644\u2013655. https:\/\/doi.org\/10.1111\/1462-2920.13062","journal-title":"Environ Microbiol"},{"issue":"5","key":"1803_CR134","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/femsec\/fiw034","volume":"92","author":"C Bardon","year":"2016","unstructured":"Bardon C, Poly F, Piola F, Pancton M, Comte G, Meiffren G, Haichar Fel Z (2016) Mechanism of biological denitrification inhibition: procyanidins induce an allosteric transition of the membrane-bound nitrate reductase through membrane alteration. FEMS Microbiol Ecol 92(5):1\u201311. https:\/\/doi.org\/10.1093\/femsec\/fiw034","journal-title":"FEMS Microbiol Ecol"},{"key":"1803_CR135","unstructured":"Sarkar D (2017) Nitrite-reductase (nirb) as potential anti-tubercular target and a method to detect the severity of tuberculosis disease. India Patent, US 9,670,523 B2"},{"issue":"6","key":"1803_CR136","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1002\/mbo3.126","volume":"2","author":"A Cunningham-Bussel","year":"2013","unstructured":"Cunningham-Bussel A, Bange FC, Nathan CF (2013) Nitrite impacts the survival of Mycobacterium tuberculosis in response to isoniazid and hydrogen peroxide. Microbiologyopen 2(6):901\u2013911. https:\/\/doi.org\/10.1002\/mbo3.126","journal-title":"Microbiologyopen"},{"issue":"4","key":"1803_CR137","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/wcms.1399","volume":"9","author":"CDD Moreira","year":"2019","unstructured":"Moreira CDD, Ramos MJRN, Fernandes PMAA (2019) Glutamine synthetase structure\u2013catalysis relationship\u2014recent advances and applications. Wires Comput Mol Sci 9(4):1\u201313. https:\/\/doi.org\/10.1002\/wcms.1399","journal-title":"Wires Comput Mol Sci"},{"issue":"9","key":"1803_CR138","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1084\/jem.189.9.1425","volume":"189","author":"G Harth","year":"1999","unstructured":"Harth G, Horwitz MA (1999) An inhibitor of exported Mycobacterium tuberculosis glutamine synthetase selectively blocks the growth of pathogenic mycobacteria in axenic culture and in human monocytes: extracellular proteins as potential novel drug targets. J Exp Med 189(9):1425\u20131435. https:\/\/doi.org\/10.1084\/jem.189.9.1425","journal-title":"J Exp Med"},{"issue":"1","key":"1803_CR139","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1128\/Iai.71.1.456-464.2003","volume":"71","author":"G Harth","year":"2003","unstructured":"Harth G, Horwitz MA (2003) Inhibition of Mycobacterium tuberculosis glutamine synthetase as a novel antibiotic strategy against tuberculosis: demonstration of efficacy in vivo. Infect Immun 71(1):456\u2013464. https:\/\/doi.org\/10.1128\/Iai.71.1.456-464.2003","journal-title":"Infect Immun"},{"issue":"16","key":"1803_CR140","doi-asserted-by":"publisher","first-page":"4790","DOI":"10.1016\/j.bmcl.2009.06.045","volume":"19","author":"LR Odell","year":"2009","unstructured":"Odell LR, Nilsson MT, Gising J, Lagerlund O, Muthas D, Nordqvist A, Karlen A, Larhed M (2009) Functionalized 3-amino-imidazo[1,2-a]pyridines: a novel class of drug-like Mycobacterium tuberculosis glutamine synthetase inhibitors. Bioorg Med Chem Lett 19(16):4790\u20134793. https:\/\/doi.org\/10.1016\/j.bmcl.2009.06.045","journal-title":"Bioorg Med Chem Lett"},{"issue":"6","key":"1803_CR141","doi-asserted-by":"publisher","first-page":"2894","DOI":"10.1021\/jm201212h","volume":"55","author":"J Gising","year":"2012","unstructured":"Gising J, Nilsson MT, Odell LR, Yahiaoui S, Lindh M, Iyer H, Sinha AM, Srinivasa BR, Larhed M, Mowbray SL, Karlen A (2012) Trisubstituted imidazoles as Mycobacterium tuberculosis glutamine synthetase inhibitors. J Med Chem 55(6):2894\u20132898. https:\/\/doi.org\/10.1021\/jm201212h","journal-title":"J Med Chem"},{"issue":"7","key":"1803_CR142","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1016\/j.bmcl.2015.02.035","volume":"25","author":"C Couturier","year":"2015","unstructured":"Couturier C, Silve S, Morales R, Pessegue B, Llopart S, Nair A, Bauer A, Scheiper B, Poverlein C, Ganzhorn A, Lagrange S, Bacque E (2015) Nanomolar inhibitors of Mycobacterium tuberculosis glutamine synthetase 1: synthesis, biological evaluation and X-ray crystallographic studies. Bioorg Med Chem Lett 25(7):1455\u20131459. https:\/\/doi.org\/10.1016\/j.bmcl.2015.02.035","journal-title":"Bioorg Med Chem Lett"},{"issue":"10","key":"1803_CR143","doi-asserted-by":"publisher","first-page":"0185068","DOI":"10.1371\/journal.pone.0185068","volume":"12","author":"A Theron","year":"2017","unstructured":"Theron A, Roth RL, Hoppe H, Parkinson C, van der Westhuyzen CW, Stoychev S, Wiid I, Pietersen RD, Baker B, Kenyon CP (2017) Differential inhibition of adenylylated and deadenylylated forms of M. tuberculosis glutamine synthetase as a drug discovery platform. PLoS ONE 12(10):0185068. https:\/\/doi.org\/10.1371\/journal.pone.0185068","journal-title":"PLoS ONE"},{"issue":"21","key":"1803_CR144","doi-asserted-by":"publisher","first-page":"22477","DOI":"10.1074\/jbc.M401652200","volume":"279","author":"R Mehta","year":"2004","unstructured":"Mehta R, Pearson JT, Mahajan S, Nath A, Hickey MJ, Sherman DR, Atkins WM (2004) Adenylylation and catalytic properties of Mycobacterium tuberculosis glutamine synthetase expressed in Escherichia coli versus mycobacteria. J Biol Chem 279(21):22477\u201322482. https:\/\/doi.org\/10.1074\/jbc.M401652200","journal-title":"J Biol Chem"},{"issue":"21","key":"1803_CR145","doi-asserted-by":"publisher","first-page":"9438","DOI":"10.1021\/acs.jmedchem.9b00747","volume":"62","author":"CV Credille","year":"2019","unstructured":"Credille CV, Morrison CN, Stokes RW, Dick BL, Feng Y, Sun J, Chen Y, Cohen SM (2019) SAR exploration of tight-binding inhibitors of influenza virus PA endonuclease. J Med Chem 62(21):9438\u20139449. https:\/\/doi.org\/10.1021\/acs.jmedchem.9b00747","journal-title":"J Med Chem"},{"key":"1803_CR146","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep31500","volume":"6","author":"M Carcelli","year":"2016","unstructured":"Carcelli M, Rogolino D, Gatti A, De Luca L, Sechi M, Kumar G, White SW, Stevaert A, Naesens L (2016) N-acylhydrazone inhibitors of influenza virus PA endonuclease with versatile metal binding modes. Sci Rep 6:1\u201314. https:\/\/doi.org\/10.1038\/srep31500","journal-title":"Sci Rep"},{"issue":"11","key":"1803_CR147","doi-asserted-by":"publisher","first-page":"4276","DOI":"10.1016\/j.ejmech.2009.07.010","volume":"44","author":"P Gupta","year":"2009","unstructured":"Gupta P, Roy N, Garg P (2009) Docking-based 3D-QSAR study of HIV-1 integrase inhibitors. Eur J Med Chem 44(11):4276\u20134287. https:\/\/doi.org\/10.1016\/j.ejmech.2009.07.010","journal-title":"Eur J Med Chem"},{"issue":"3","key":"1803_CR148","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1021\/ol503580t","volume":"17","author":"H Wang","year":"2015","unstructured":"Wang H, Kowalski MD, Lakdawala AS, Vogt FG, Wu L (2015) An efficient and highly diastereoselective synthesis of GSK1265744, a potent HIV integrase inhibitor. Org Lett 17(3):564\u2013567. https:\/\/doi.org\/10.1021\/ol503580t","journal-title":"Org Lett"}],"container-title":["JBIC Journal of Biological Inorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00775-020-01803-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00775-020-01803-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00775-020-01803-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T23:07:33Z","timestamp":1626390453000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00775-020-01803-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,16]]},"references-count":148,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["1803"],"URL":"https:\/\/doi.org\/10.1007\/s00775-020-01803-1","relation":{},"ISSN":["0949-8257","1432-1327"],"issn-type":[{"value":"0949-8257","type":"print"},{"value":"1432-1327","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,16]]},"assertion":[{"value":"24 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"There are no conflicts to be disclosed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}